Dan Nathan Sees Unusual Options Activity In This Biotech ETF By: Benzinga via Benzinga September 20, 2016 at 06:32 AM EDT On CNBC's Options Action, Dan Nathan spoke about an options trade in SPDR S&P Biotech (ETF) (NYSE: XBI) that he noticed on ... Read More >> Related Stocks: S&P Biotech SPDR